Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer

Clinical trial NCT00005655 · TERMINATED

Trial details

NCT number: NCT00005655
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Kidney Neoplasm Lung Neoplasm Sarcoma Breast Neoplasm

Start date: 2000-04-28
Primary completion: 2010-10-06
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.